How should I prepare a vasopressin solution by diluting 20 units in 50 mL of sterile diluent?

Vasopressin 20 Units Diluted in 50 mL: Preparation and Administration

Dilute vasopressin 20 units in 50 mL of normal saline (0.9% sodium chloride) or 5% dextrose in water (D5W) to create a 0.4 units/mL concentration for intravenous infusion. This is a standard and safe dilution method supported by FDA labeling and clinical practice 1.

Preparation Guidelines

The FDA-approved vasopressin injection (20 units/mL) must be diluted before intravenous administration 1. Your proposed dilution of 20 units in 50 mL creates a concentration of 0.4 units/mL, which falls within acceptable clinical practice ranges.

Specific Dilution Instructions:

• Take 1 mL of vasopressin 20 units/mL (containing 20 units)
• Add to 49 mL of diluent (normal saline or D5W) to achieve 50 mL total volume
• Final concentration: 0.4 units/mL (20 units/50 mL)
• Stability: Discard after 18 hours at room temperature or 24 hours if refrigerated 1

Clinical Context and Dosing

This concentration is appropriate for continuous infusion in shock states. The Surviving Sepsis Campaign guidelines recommend vasopressin 0.03 units/minute as an adjunct to norepinephrine in septic shock 2. With your 0.4 units/mL concentration:

• Starting dose for septic shock: 0.01 units/min = 1.5 mL/hour
• Typical dose for post-cardiotomy shock: 0.03 units/min = 4.5 mL/hour
• Maximum recommended dose: 0.03-0.04 units/min for routine use; higher doses (up to 0.1 units/min) reserved for salvage therapy 2, 1

Titrate by 0.005 units/minute increments every 10-15 minutes until target mean arterial pressure (MAP) of 65 mmHg is achieved 1.

Alternative Concentrations in Practice

While your 20 units/50 mL dilution is acceptable, be aware that other institutions use different concentrations:

• More concentrated: 20 units/100 mL (0.2 units/mL) - increasingly adopted to reduce waste and costs 3, 4
• Less concentrated: 20 units/250 mL (0.08 units/mL) - traditional formulation but associated with more waste 3

The choice of concentration doesn't affect clinical efficacy but impacts waste and cost. Recent studies show that more concentrated formulations (like 20 units/100 mL) reduce waste by approximately 40% without compromising patient outcomes 3, 4.

Critical Safety Considerations

Administration Route:

• Requires central venous access traditionally, though recent evidence supports peripheral administration of dilute vasopressin solutions (e.g., 8-40 µg/mL) through peripheral IV when central access unavailable 5, 6
• Your 0.4 units/mL (400 µg/mL) concentration is too concentrated for safe peripheral administration - use central line

Monitoring Requirements:

• Arterial catheter placement recommended for all patients requiring vasopressors 2
• Continuous hemodynamic monitoring essential
• Monitor for arrhythmias, especially at higher doses

Timing Considerations:

Add vasopressin early (within 3 hours of starting norepinephrine) rather than waiting for high norepinephrine doses. Early addition (<3 hours) is associated with faster shock resolution (37.6 vs 60.7 hours) and shorter ICU stay 7. This contradicts older practice of waiting until norepinephrine exceeds 0.25-0.5 µg/kg/min.

Weaning Strategy:

After target blood pressure maintained for 8 hours without catecholamines, taper vasopressin by 0.005 units/minute every hour as tolerated 1.

Common Pitfalls to Avoid

1. Don't use vasopressin as first-line vasopressor - norepinephrine remains first-line 2, 5
2. Don't exceed 0.03-0.04 units/minute routinely - higher doses increase adverse effects without clear benefit 2, 1
3. Don't delay addition waiting for very high norepinephrine doses - earlier addition (within 3 hours) improves outcomes 7
4. Don't administer concentrated solutions peripherally - risk of severe tissue injury from extravasation

Your proposed 20 units in 50 mL dilution is clinically appropriate and ready for use via central venous access in patients with vasodilatory shock requiring vasopressor support.